DENNIS CARSON: Open Payments
NPI 1982816294 · ELYRIA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,966 in 108 payments from 22 companies in 2025. Trend: 2023 $2,178 · 2024 $2,006 · 2025 $1,966
Food & beverage: $1,966
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 20 | $403 |
| AstraZeneca Pharmaceuticals LP | 11 | $190 |
| Novo Nordisk Inc | 11 | $170 |
| Lilly USA, LLC | 8 | $134 |
| GlaxoSmithKline, LLC. | 8 | $128 |
| PFIZER INC. | 7 | $111 |
| ABBVIE INC. | 5 | $109 |
| E.R. Squibb & Sons, L.L.C. | 5 | $92 |
| Xeris Pharmaceuticals, Inc. | 4 | $91 |
| Janssen Pharmaceuticals, Inc | 4 | $86 |
Products named: REXULTI, AIRSUPRA, Wegovy, SPRAVATO, MOUNJARO, Ozempic, TRELEGY ELLIPTA, NURTEC ODT.
Industry payments across OH — which companies pay providers there.
